0001209191-21-063671.txt : 20211109 0001209191-21-063671.hdr.sgml : 20211109 20211109172533 ACCESSION NUMBER: 0001209191-21-063671 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211105 FILED AS OF DATE: 20211109 DATE AS OF CHANGE: 20211109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Simeone Jill CENTRAL INDEX KEY: 0001581731 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36911 FILM NUMBER: 211393383 MAIL ADDRESS: STREET 1: C/O ETSY STREET 2: 117 ADAMS STREET CITY: BROOKLYN STATE: NY ZIP: 11201 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ETSY INC CENTRAL INDEX KEY: 0001370637 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 117 ADAMS STREET CITY: BROOKLYN STATE: NY ZIP: 11201 BUSINESS PHONE: (718) 880-3660 MAIL ADDRESS: STREET 1: 117 ADAMS STREET CITY: BROOKLYN STATE: NY ZIP: 11201 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-11-05 0 0001370637 ETSY INC ETSY 0001581731 Simeone Jill C/O ETSY, INC. 117 ADAMS STREET BROOKLYN NY 11201 0 1 0 0 Chief Legal Officer Common Stock 2021-11-05 4 M 0 12730 12.46 A 30322 D Common Stock 2021-11-05 4 M 0 22709 14.72 A 53031 D Common Stock 2021-11-05 4 M 0 15000 28.38 A 68031 D Common Stock 2021-11-05 4 S 0 6672 257.58 D 61359 D Common Stock 2021-11-05 4 S 0 23103 258.38 D 38256 D Common Stock 2021-11-05 4 S 0 7400 259.79 D 30856 D Common Stock 2021-11-05 4 S 0 1690 260.53 D 29166 D Common Stock 2021-11-05 4 S 0 16700 261.99 D 12466 D Common Stock 2021-11-05 4 S 0 1476 263.38 D 10990 D Common Stock 2021-11-05 4 S 0 124 264.10 D 10866 D Common Stock 2021-11-09 4 M 0 2250 28.38 A 13116 D Common Stock 2021-11-09 4 S 0 2250 261.00 D 10866 D Stock Option (Right to Buy) 12.46 2021-11-05 4 M 0 12730 0.00 D 2027-01-31 Common Stock 12730 0 D Stock Option (Right to Buy) 14.72 2021-11-05 4 M 0 22709 0.00 D 2027-07-02 Common Stock 22709 0 D Stock Option (Right to Buy) 28.38 2021-11-05 4 M 0 15000 0.00 D 2028-03-14 Common Stock 15000 24303 D Stock Option (Right to Buy) 28.38 2021-11-09 4 M 0 2250 0.00 D 2028-03-14 Common Stock 2250 22053 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $256.93 to $257.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $257.93 to $258.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $259.19 to $260.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $260.22 to $260.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $261.61 to $262.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $262.93 to $263,85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $264.045 to $264.125, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $260.97 to $261.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The shares underlying the option exercised in this transaction were fully vested and exercisable. 25% of the stock options became exercisable on February 1, 2018, with the remainder of the originally granted options exercisable in 36 equal monthly installments beginning on March 1, 2018, provided the Reporting Person remains continuously employed on each vesting date. The shares underlying the option exercised in this transaction were fully vested and exercisable. 25% of the stock options became exercisable on July 3, 2018, with the remainder of the originally granted options exercisable in 36 equal monthly installments beginning on August 3, 2018, provided the Reporting Person remains continuously employed on each vesting date. The shares underlying the option exercised in this transaction were fully vested and exercisable. The stock options become exercisable in 8 equal semi-annual installments, beginning on October 1, 2018, provided the Reporting Person remains continuously employed on each vesting date. /s/ Brittany Keen, as Attorney-in-Fact for Jill Simeone 2021-11-09